
IGF-1 LR3 1mg
Synthetic Peptide for Cellular Growth and Receptor Research
$123.00
Out of stock
IGF-1 LR3 (For Research Use Only)
Synthetic Peptide for Cellular Growth and Receptor Research
Product Description
IGF-1 LR3 is a synthetic 83-amino-acid peptide and a modified analog of Insulin-Like Growth Factor-1 (IGF-1), designed exclusively for laboratory research. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, it is intended for use in controlled in vitro and preclinical animal studies to investigate cellular growth, receptor signaling, and metabolic pathways. Not for human consumption, therapeutic use, or diagnostic applications.Research Applications
In Vitro Studies: Suitable for cell culture experiments, such as investigating IGF-1 LR3’s binding to IGF-1 receptors in myoblast cell lines (e.g., C2C12 cells) to study cellular proliferation and differentiation pathways.
Preclinical Models: Ideal for animal-based research, such as rodent models (e.g., mice or rats) to examine IGF-1 LR3’s effects on tissue growth or repair mechanisms in controlled settings, such as models of induced muscle or bone injury.
Biochemical Analysis: Can be used to study peptide stability, receptor binding affinity, or downstream effects on cellular processes, such as PI3K/Akt signaling pathways, in laboratory environments.
Mechanism of Action (Research Context)
IGF-1 LR3 interacts with IGF-1 receptors in experimental models, enabling researchers to study:
Modulation of cellular growth and differentiation in myoblast or osteoblast cell cultures.
Effects on tissue repair or metabolic signaling in preclinical animal models, such as rats with controlled musculoskeletal stress protocols.
Interactions with cellular signaling cascades, such as Akt/mTOR pathways, in controlled in vitro systems like primary cell cultures or tissue explants.
Product Specifications
Purity: ≥98% (verified by HPLC, with Certificate of Analysis provided).
Form: Lyophilized powder for reconstitution in laboratory-grade solvents.
Storage: Store at -20°C in a dry, controlled environment to maintain stability for research purposes.
Packaging: Supplied in sterile vials for laboratory use.
Important Notes
For Research Use Only: This product is strictly intended for laboratory research by qualified professionals. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes.
Researcher Verification: Orders require confirmation of institutional or academic affiliation to ensure compliance with RUO regulations.
Safety: Handle in accordance with laboratory safety protocols. Not tested for human safety or efficacy.
Ordering Information
Available for purchase by research institutions, academic laboratories, and biotechnology firms.
Each order includes a Certificate of Analysis from an FDA-registered manufacturer to ensure quality for research applications.
Disclaimer
IGF-1 LR3 is provided exclusively for scientific research and is not approved for human consumption, medical use, or distribution outside of research settings. Any use beyond laboratory research is strictly prohibited. Customers are responsible for ensuring compliance with all applicable regulations.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.